| P/E (FY) | — | Sales (TTM) | — |
| Earnings (TTM) | -$14.2M | ROE | −32.42% |
| Net Margin | — | ROIC | — |
| Debt / Equity | — | TD / EBITDA | — |
| EPS Growth 3Y | — | Sales Growth 3Y | — |
| Market Cap | $112.8M | Trading Days | 5267 |
| 52W High | 4.67 |
| 52W Low | 1.60 |
| % Off High | −64.03% |
| YTD | −16.00% | 1Y | −42.07% |
| 3Y | −29.41% | 5Y | −76.44% |
| 10Y | −96.73% | Since incept. (ann.) | −40.05% |
| Ann. Volatility (1Y) | 79.81% | Ann. Volatility (3Y) | 103.88% |
| Sharpe (1Y) | −0.31 | Sharpe (3Y) | 0.35 |
| Max Drawdown (1Y) | −64.00% | Max Drawdown (3Y) | −65.99% |
| Beta (3Y, vs SPY) | 0.56 |
| Ticker | Name | Mkt cap | P/E |
|---|---|---|---|
| GUTS | FRACTYL HEALTH, INC. | $114.6M | — |
| STIM | Neuronetics, Inc. | $130.1M | — |
| CVRX | CVRx, Inc. | $131.4M | — |
| SKIN | SkinHealth Systems Inc. | $90.5M | — |
| RCEL | AVITA Medical, Inc. | $141.9M | — |
| APYX | Apyx Medical Corp | $161.6M | — |
| XAIR | Beyond Air, Inc. | $78.7M | — |
| PDEX | PRO DEX INC | $179.9M | 21.1 |
| KRMD | KORU Medical Systems, Inc. | $184.2M | — |
| LUCD | Lucid Diagnostics Inc. | $185.7M | — |
| NMTC | NEUROONE MEDICAL TECHNOLOGIES Corp | $67.1M | — |
| LNSR | LENSAR, Inc. | $64.8M | — |
